These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9636919)

  • 21. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
    Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
    Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of angiotensin II to treat profound hypotension in a patient taking amiodarone.
    Geary VM; Thaker UN; Chalmers PC; Sheikh F
    J Cardiothorac Anesth; 1990 Jun; 4(3):364-7. PubMed ID: 2131887
    [No Abstract]   [Full Text] [Related]  

  • 23. Vasopressin for refractory hypotension during cardiopulmonary bypass.
    McGaw C; Scarlett M; Irvine R; Ramphal P
    West Indian Med J; 2007 Dec; 56(6):550-4. PubMed ID: 18646503
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodarone.
    Blomberg PJ; Feingold AD; Denofrio D; Rand W; Konstam MA; Estes NA; Link MS
    Am J Cardiol; 2004 Feb; 93(3):379-81. PubMed ID: 14759399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicorandil-induced peripheral vasodilatation during cardiopulmonary bypass.
    Falase BA; Bajaj BS; Wall TJ; Argano V; Youhana AY
    Ann Thorac Surg; 1999 Apr; 67(4):1158-9. PubMed ID: 10320271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyponatremia in heart failure].
    Riegger AJ
    Z Kardiol; 1988; 77 Suppl 3():55-6. PubMed ID: 3213151
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of preoperative amiodarone treatment may be associated with postoperative hospital mortality in patients undergoing heart transplantation.
    Chin C; Feindel C; Cheng D
    J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):562-6. PubMed ID: 10527225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality.
    Kittleson M; Hurwitz S; Shah MR; Nohria A; Lewis E; Givertz M; Fang J; Jarcho J; Mudge G; Stevenson LW
    J Am Coll Cardiol; 2003 Jun; 41(11):2029-35. PubMed ID: 12798577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin for refractory hypotension during cardiopulmonary bypass.
    Talbot MP; Tremblay I; Denault AY; Bélisle S
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):401-2. PubMed ID: 10917960
    [No Abstract]   [Full Text] [Related]  

  • 30. SIADH induced by amiodarone in a patient with heart failure.
    Paydas S; Araz F; Balal M
    Int J Clin Pract; 2008 Feb; 62(2):337. PubMed ID: 18199281
    [No Abstract]   [Full Text] [Related]  

  • 31. Pro: Vasopressin is the vasoconstrictor of choice after cardiopulmonary bypass.
    Booth JV; Schinderle D; Welsby IJ
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):773-5. PubMed ID: 12486663
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
    DiBianco R
    Postgrad Med; 1985 Oct; 78(5):229-41, 244, 247-8. PubMed ID: 2864682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin and postcardiopulmonary bypass refractory hypotension.
    Licker M; Schweizer A
    Anesth Analg; 1999 Mar; 88(3):695. PubMed ID: 10072037
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass.
    Tuman KJ; McCarthy RJ; O'Connor CJ; Holm WE; Ivankovich AD
    Anesth Analg; 1995 Mar; 80(3):473-9. PubMed ID: 7864410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
    Tsuda E; Matsuo M; Sakaguchi H; Hayashi T; Hosoda K; Miyazaki A
    Pediatr Int; 2010 Feb; 52(1):e39-42. PubMed ID: 20158646
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
    Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity.
    Doria C; Elia ES; Kang Y; Adam A; Desormeaux A; Ramirez C; Frank A; di Francesco F; Herman JH
    Liver Transpl; 2008 May; 14(5):684-7. PubMed ID: 18433037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypotension followed the first dose of angiotensin-converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial)].
    Moiseev VS; Tereshchenko SN; Aleksandriia LG; Kobalava ZhD
    Ter Arkh; 2001; 73(9):61-6. PubMed ID: 11642085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.